The Role of 99mTc-MIBI Scintigraphy in the Diagnosis of Soft Tissue Sarcomas
https://doi.org/10.37174/2587-7593-2018-1-1-31-36
Abstract
Purpose: To determine the diagnostic and therapeutic prognostic possibilities of 99mTc-MIBI scintigraphy in the study of soft tissue sarcomas.
Material and methods: The study included 37 primary patients. All conducted two-phase 99mTc-MIBI scanning.
Results: It was defined the correlation between the level of accumulation of radiopharmaceuticals in the tumor from the degree of tumor differentiation. It was defined the relationship of the level of “washout” of the 99mTc-MIBI from the tumor before treatment and the degree of therapeutic pathomorphosis.
Conclusion: 1. The relationship between 99mTc-MIBI affinity to the tumor and degree of differentiation is weak (r = –0,2177, p < 0.05).
2. The relationship between the rate of 99mTc-MIBI “washout” from the tumor and chemotherapy response is weak (r = –0,1964, p <0.05).
About the Authors
A. S. KrylovRussian Federation
Moscow
A. D. Ryzhkov
Russian Federation
Moscow
Ja. A. Shchipakhina
Russian Federation
Moscow
S. V. Shiryaev
Russian Federation
Moscow
References
1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в Росcии и странах СНГ в 2012 г. – М.: Издательская группа РОНЦ. 2014. 226 с.
2. Ширяев С.В. Ядерная медицина в онкологии // Энциклопедия Клинической онкологии. Под ред. М.И. Давыдова – М.: РЛС. 2004. С. 117–125.
3. Лишманов Ю.Б., Чернов В.И. Радионуклидная диагностика для практических врачей. – Томск: STT. 2004. С. 370.
4. Hicks R.J., Toner G.C., Choong P.F. Clinical applications of molecular imaging in sarcoma evaluation // Cancer Imaging. 2005. № 5. P. 66–72.
5. Moon L., McHugh K. Advances in pediatric tumors imaging // Arch. Dis. Child. 2005. Vol. 90. № 6. P. 608–611.
6. Cordon-Cardo C., O’Brien J.P., Boccia J. et al. Expression of multidrug-resistance gene product(p-glycoprotein) in human normal and tumor tissues // J. Histochem. Cytochem. 1990. Vol. 38. P. 1144–1150.
7. Vecchio S.D., Ciarmiello A., Potena M.I. et al. In vivo detection of multidrug-resistant (MDR1) phenotype by 99m-Tc sestamibi scan in untreated breast cancer patients // Eur. J. Nucl. Med. 1997. Vol. 37. P. 286 –289.
8. Salvatore M., Del Vecchio S. Dynamic imaging: scintimammography // Eur. J. Radiol. 1998. Vol. 27. № 2. P. 259– 264.
9. Sergieva S.B., Timcheva K.V,. Hadjiolov N.D. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients // J BUON. 2006. Vol. 11. № 1. P. 61–68.
10. Крылов А.С., Поляков В.Г., Ширяев С.В. Сцинтиграфия с 67Ga-цитратом и 99mTc-технетрилом в первичной диагностике сарком мягких тканей у детей // Детская онкология. 2011. № 1. С. 23–32.
11. Крылов А.С., Поляков В.Г., Ширяев С.В. Оценка эффективности лечения сарком мягких тканей у детей при помощи сцинтиграфии с 99mTc-технетрилом и 67Ga-цитратом // Онкопедиатрия. 2014. № 2. С. 42–48.
12. Moustafa H., Riad R., Omar W. et al. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone soft tissue tumours of the extremities // Q. J. Nucl. Med. 2003. Vol. 47. P. 51–57.
13. Garcia R., Kim E.E., Wong F.C. et al. Comparison of fluorine18-FDG PET and technetium-99m-MIBI SPECT in evaluation of muscu-loskeletal sarcomas // J. Nucl. Med. 1996. Vol. 37. P. 1476–1479.
14. Sergieva S.B., Timcheva K.V., Hadjiolov N.D. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients // J BUON. 2006. Vol. 11. № 1. P. 61–68.
15. Mohan H.K., Miles K.A. Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis // J. Nucl. Med. 2009. Vol. 50. № 3. P. 376–381.
Review
For citations:
Krylov A.S., Ryzhkov A.D., Shchipakhina J.A., Shiryaev S.V. The Role of 99mTc-MIBI Scintigraphy in the Diagnosis of Soft Tissue Sarcomas. Journal of oncology: diagnostic radiology and radiotherapy. 2018;1(1):31-36. (In Russ.) https://doi.org/10.37174/2587-7593-2018-1-1-31-36